Good MorningEquity markets will open near an all-time high following the Juneteenth holiday and will likely continue higher over the summer. The FOMC and inflation remain reasons to worry but have become a pile of bricks used to build a Wall of Worry that keeps increasing. The market is moving higher on earnings growth and will likely rally until the outlook for earnings changes, and there are only two possibilities to look forward to.
The first is a soft landing for the economy, an interest rate cut, and S&P 500 earnings stability, if not growth. The second scenario includes a hard landing, recession, and earnings contraction. In the first scenario the S&P 500 can continue to rally indefinitely, in the second a significant correction would follow. The question for investors is if the economy can sustain growth until the FOMC cuts rates or if it will reach its peak and begin to recede before they do. As it is, the first cut isn't expected until November, and it may not come then. Featured: 25 candidates screened. 5 made it. (Ad) 
|
Healthcare | |
Outlook Therapeutics (NASDAQ: OTLK) has gained attention, with analysts forecasting an upside of over 500% based on the consensus price target.
It's essential to remember that low-float biopharmaceutical companies often experience volatility due to frequent breaking news and technical factors ... Read the Full Story |
|
From Our Partners | | Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies.
Dr. Mark Skousen, who met Musk in person and called the SpaceX listing months early, says he has identified all three targets in what he calls Elon's $2.1 Trillion Hit List.
See the three companies before the rumors become headlines. | | Get the details on all three companies now |
|
Consumer Staples | |
Global food and beverage company Campbell Soup Co. (NYSE: CPB) reported solid earnings accompanied by raised guidance, but the market continued to sell off shares. However, clues were sprinkled throughout its earnings presentation that indicate a return of growth acceleration is coming in the se... Read the Full Story |
|
Technology | |
Zebra Technologies (NASDAQ: ZBRA) stock hit bottom in 2023, but it took until this year for the reversal to be completed. Now, the stock is up 50% from the recent low and heading higher under the influence of analysts. Analysts' sentiments also bottomed during the last twelve months, and a rever... Read the Full Story |
|
From Our Partners | | A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years.
While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million.
One company controls the entire supply chain behind this discovery. | | See the ticker behind this Grand Canyon energy breakthrough now |
|
Energy | |
Oil prices (NYSEARCA: USO) are near the low end of a multi-year trading range, aiding the broad market rally in stocks. Oil prices are a fundamental driver of inflation that compounds within the economy, and the inflation outlook is driving the market. Lower oil prices undercut inflation.
The ... Read the Full Story |
|
Healthcare | |
The Alzheimer's treatment landscape presents a compelling opportunity for investors in healthcare and biotech. Alzheimer's disease is a progressive and debilitating neurodegenerative disorder that poses a significant and growing threat to global health and economic well-being. With an estimated 6.... Read the Full Story |
|
From Our Partners | | Barrick Mining has spent decades building one of the world's great gold districts in Nevada, anchored by Fourmile, Goldrush, and Cortez Hills, a region that could hold as much as 60 million ounces of gold.
Bordering Fourmile and less than a mile from Goldrush sits a little-known explorer now moving from historical data toward active exploration, setting targets and preparing for a maiden drilling program.
With gold trading near record highs, this could be a pivotal stage for an overlooked name in the district. | | See why this overlooked gold explorer could be entering its most important stage |
|
Finance | |
The typical advice in the financial market is to never blindly follow a whale investor like Warren Buffett. However, these investors' reverse-engineering investment decisions can often prove helpful. Today, Warren Buffett didn't buy more shares of Occidental Petroleum Co. (NYSE: OXY) because the e... Read the Full Story |
|
Industrials | |
3M (NYSE: MMM) is turning a corner. The company wasn’t hurt by ailing business so much as lawsuits related to legacy businesses that are now primarily in the past. The settlements may still be appealed or amended, but the $18-odd billion in damages is close to the final payments expected. Th... Read the Full Story |
|
Technology | |
The artificial intelligence (AI) sector is experiencing explosive growth, captivating investors and sending ripples through the stock market. Super Micro Computer (NASDAQ: SMCI) is a leading high-performance computing and AI infrastructure provider. Super Micro’s financials show that it has ... Read the Full Story |
|
Consumer Discretionary | |
VinFast Auto Ltd. (NASDAQ: VFS) is a Vietnamese manufacturer of electric vehicles (EVs), e-buses, and e-scooters. The start-up company is pursuing an aggressive EV expansion strategy growing in the United States, Europe and Southeast Asia. VinFast officially signed agreements with 12 new dealers... Read the Full Story |
|
Consumer Discretionary | |
Plant-based meat producer Beyond Meat Inc. (NASDAQ: BYND) has a 39.81% short interest. Sentiment is negative for the stock as it continues to fall lower, trading down more than 25% year-to-date (YTD). The stock recently provided investors with a fleeting lifeline, briefly jumping to $10.31 on a sh... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel. | | View Today's Stock Pick |
|
